Why the study?
When Takotsubo cardiomyopathy is due to a life-threatening arrhythmia such as atrioventricular block, several considerations must be made regarding treatment.
Case Report (n=1)
No
In a patient with Takotsubo cardiomyopathy triggered by high-grade AV block, treatment with a pacemaker and beta-blockers led to clinical and echocardiographic recovery.
INTRODUCTION: Takotsubo cardiomyopathy (TTC) is a condition with a good long-term prognosis. However, when the TTC is due to a life-threatening arrhythmia, such as atrioventricular block (AVB), several considerations must be made regarding treatment. CASE PRESENTATION: A 71-year-old woman with a history of ischemic stroke presented after a syncopal episode. Before passing out, the patient was walking, nauseous, lightheaded, dizzy, and short of breath. In the emergency department, the blood pressure was 230/120 mmHg, and the heart rate was 38 beats per minute, but the patient was asymptomatic. An electrocardiogram showed a new-onset 2:1 AVB, bifascicular block, and prolonged PR and corrected QT intervals. An echocardiogram revealed a new-onset ejection fraction of 30% to 35%; hypokinesis of the apex, mid-inferoseptum, mid-anterolateral, apical to mid-inferior, and apical to mid-anterior walls; and hyperkinesis of the basal segments. The cardiac catheterization illustrated normal coronary arteries without significant stenosis. Therefore, the patient was diagnosed with TTC and 2:1 AVB. She was treated with lisinopril and metoprolol succinate and received a dual-chamber pacemaker. At the follow-up visit, the patient's ejection fraction and hypokinetic segments improved. She denied any recurrence of syncope, and her pacemaker was functioning appropriately. CONCLUSION: When AVB or other arrhythmias initiate a TTC, the patient can experience sudden cardiac death and decompensate quickly. Therefore, clinicians should understand this rare but fatal complication because these patients require pacemakers and beta blockers.
No takes yet. Share an insight, caveat, or question.
Prasad et al. (2021) conducted a case report in Takotsubo cardiomyopathy and high-grade atrioventricular block (n=1). Lisinopril, metoprolol succinate, and dual-chamber pacemaker was evaluated on Improvement in ejection fraction and wall motion abnormalities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: